September 5, 2018

General Session – Dr. Kathleen Blake, MD, MPH, will describe the value of NESTcc for stakeholder groups, with special emphasis on clinicians. Interim Governing Committee Chair Michelle McMurry-Heath, MD, PhD, will share her vision for the role of NESTcc in opening the front door to targeted test-case initiatives while Jeffrey Shuren, MD, JD will discuss the role of NESTcc in addressing FDA pre- and post-market priorities.

Breakout Session – Doctors Lesley Curtis, PhD, MS, and Joe Drozda, MD, FACC, will share insights as test-case project leaders, including lessons learned, the benefits of working with NESTcc, and innovative solutions. Dr. Curtis will also provide insights as the Chair of the NESTcc Data Quality Committee. Dr. Paul Coplan, ScD, MBA, FISPE, will provide an industry perspective on the value of the NESTcc test-case initiative.


General Session Moderator: Rachael Fleurence, PhD | Executive Director | National Evaluation System for health Technology Coordinating Center

Breakout Session Moderator: Owen Faris, PhD | Clinical Trials Director | Office of Device Evaluation, Center for Devices and Radiological Health, U.S. Food and Drug Administration


Center for Total Health
700 Second St. NE
Washington, DC 20002
View Map


Register Here. 

Follow us @NESTccMedTech

At the MDEpiNet RAPID Phase III Pathways Meeting today, NESTcc Data Network Director @robbert_z presented an update on the current status of NESTcc as part of an expert panel. More: 5 days ago

We are hiring for a Business Development Manager to support NESTcc's growth and stakeholder engagement initiatives. Learn more about our open positions on the MDIC careers page: 2 weeks ago

National Evaluation System for health Technology Coordinating Center (NESTcc)
1501 Wilson Blvd., Suite 910, Arlington, VA 22209

© Copyright 2020 | Privacy Policy

An Initiative of:

MDIC logo

Follow MDIC:

Twitter logo
LinkedIn Logo